CUSIP 23284F105COMCTMXQ4 2025
64 filings · latest Mar 4, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Fmr LLC | 24.69M | $105.17M |
| 2 | Vr Adviser, LLC | 15.56M | $66.29M |
| 3 | Perceptive Advisors LLC | 9.68M | $41.24M |
| 4 | Kynam Capital Management, LP | 8.97M | $38.20M |
| 5 | Vanguard Group Inc | 8.48M | $36.11M |
| 6 | Commodore Capital LP | 7.69M | $32.77M |
| 7 | Point72 Asset Management, L.P. | 5.19M | $22.11M |
| 8 | State Street Corp | 5.14M | $21.90M |
| 9 | Baker Bros. Advisors LP |
| 4 | Feb 5, 2026 | Fmr LLC | 13G/A | 14.6% | 24.69M | SEC |
| 5 | Nov 14, 2025 | Venrock Healthcare Capital Partners III, L.P. | 13G/A | 9.4% | 15.56M | SEC |
| 6 | Nov 14, 2025 | Seven Fleet Master Fund LP | 13G/A | 0.0% | 48.9K | SEC |
| 7 | Nov 14, 2025 | Point72 Asset Management, L.P. | 13G/A | 2.5% | 4.07M | SEC |
| 8 | Nov 7, 2025 | Fmr LLC | 13G/A | 12.4% | 20.52M | SEC |
| 9 | Nov 5, 2025 | Fmr LLC | 13G/A | 9.3% | 15.40M | SEC |
| 10 | Aug 21, 2025 | Perceptive Advisors LLC | 13G | 5.9% | 9.68M | SEC |
See the full Schedule 13D/13G history for Cytomx Therapeutics Inc.
Unlock full history| 4.25M |
| $18.11M |
| 10 | Adar1 Capital Management, LLC | 4.18M | $17.82M |